• Genomic Medicine Training, New Storage Options, Food Allergy Science

    Bio-IT World | News and product launches from around the Bio-IT landscape include a postdoctoral fellowship in genomics medicine in Alabama, a synthetic biology partnership, new Lustre storage, and the Broad's food allergy science institute.

    Jul 12, 2016

  • A Drug For Postpartum Depression? Sage Passes Early Test With Experimental Treatment

    Forbes | Encouraging news is out today for the treatment of severe postpartum depression. Sage Therapeutics, a biotech company in Cambridge, Mass., reported that its experimental drug was able to relieve severe symptoms of postpartum depression for 70% of patients within a few days, and keep them in remission for a month.

    Jul 12, 2016

  • Intel's Cancer Cloud: Complementing NCI Collaboration

    Bio-IT World | Intel may have missed out on a major government grant, but that hasn't stopped it from developing a collaborative cloud for genomicists and bioinformaticians that it wanted to build all along.

    Jul 11, 2016

  • IT spending will shrink worldwide due to Brexit Gartner predicts

    Computerworld | Britain's vote to exit the European Union will depress global IT spending, according to Gartner analyst John-David Lovelock.

    Jul 8, 2016

  • Juno Therapeutics Stops Trial Of Cancer-Killing Cells After 3 Patient Deaths

    Forbes | Three patients have died in a closely watched study of using genetically engineered white blood cells to treat adult leukemia patients, forcing the trial to be put on hold. The news is a blow for Juno Therapeutics, the biotechnology startup valued at $4.3 billion.

    Jul 8, 2016

  • Obama Seeks To Make Mark On Genetic Medicine

    Forbes | After a few weeks of hype around the Obama administration's efforts to speed cancer research, officials tonight announced plans to kickstart efforts around the president's Precision Medicine Initiative.

    Jul 7, 2016

  • Cloud Adoption Numbers Are All Over the Map

    Fortune | Johnson & Johnson turned off its last mainframe and plans to move 85% of its software to the cloud. Is it mainstream or an outlier?

    Jul 7, 2016

  • Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M

    Xconomy | Bind Therapeutics and its treatment for treatment for non-small cell lung cancer may soon be owned by one-time partner Pfizer. Bind, which filed for Chapter 11 bankruptcy in May asked the court to approve a bid from Pfizer on July 1.

    Jul 6, 2016

  • Owning Your Data: The Genos Model

    Bio-IT World | Consumer genomics startup, Genos, is expanding its beta program and inviting Bio-IT World readers to sequence their whole exome at CLIA-certified 75x coverage for $399.

    Jul 5, 2016

  • Building Amgen’s RWD Platform

    Bio-IT World | Best Practices Amgen built a Real World Data platform to provide an enterprise-wide capability to better access and analyze available claims, electronic health records (EHRs), and cohort data, and address questions across the clinical and health IT development lifecycle.

    Jul 1, 2016

  • PrecisionFDA Announces Truth Challenge Winners

    Bio-IT World  PrecisionFDA announced the results of its Truth Challenge today. Entries from Verily Life Sciences, Kinghorn Center for Clinical Genomics, and Sanofi-Genzyme won top recognition. In addition to the winners, DNAnexus, Roche, Real Time Genomics, Sentieon, Qunitiles, Macrogen, the Broad Institute, and others participated.

    Jun 29, 2016

  • New Investments, Projects Spur Moonshot Program Forward

    Bio-IT World The Cancer Moonshot Summit today served as a platform for many announcements from both the public and private sectors on ways to advance the Moonshot’s goals.

    Jun 29, 2016

  • Pfizer plans $350M China biotech plant

    USA TODAY | U.S. drug-making giant Pfizer plans to invest roughly $350 to develop a biotechnology center in China, increasing the company's footprint in the world's second-largest pharmaceutical market, the firm said Monday.

    Jun 28, 2016

  • Democratizing Data in Canada

    Bio-IT World | Molecular You (MYCo) has a vision to decipher a wide variety of individual patient data to promote health, detect disease in its earliest stages, and provide insights on therapeutic efficacy and timing. To manage a broad range of data, MYCo has enlisted a data warehouse solution built on Hadoop.

    Jun 24, 2016

  • Bio-IT World’s Editors’ Choice Award: XAbTracker and SeqAgent

    Bio-IT World | Best Practices Award | Each year, the Bio-IT World Conference & Expo welcomes innovators from around the world who come to share their best practices, and glean insight from others. This year, XOMA’s applications XAbTracker and SeqAgent stood out for doing just that. Their team targeted a bottleneck in the antibody discovery process and developed two software programs specifically designed to improve data analysis with both speed and efficiency.

    Jun 23, 2016

  • AWS and Azure clouds gain security OK from feds

    Computerworld | Three vendors, including Microsoft and Amazon Web Services, have won a key U.S. government authorization that will allow federal agencies to put highly sensitive data on the cloud-computing services.

    Jun 23, 2016

  • Intel SAP other tech companies pledge to get more inclusive in hiring

    Computerworld | Intel, SAP, Lyft, Spotify and VMware are among more than 30 Silicon Valley companies to sign a pledge that they would take action to make their technology workforce "fully representative of the American people, as soon as possible."

    Jun 23, 2016

  • Buy-in from the top is key to cloud transitions AWS exec says

    Computerworld | As the head of Amazon Web Services, Andy Jassy has seen a lot of big organizations start using the public cloud. The biggest indicator of success for a cloud transition is simple, he says: Has the business' senior staff bought into it?

    Jun 22, 2016

  • Federal Oversight Group Has Complaints But Says Yes To CRISPR Trial

    Xconomy | Despite worries about conflict of interest, a National Institutes of Health committee that oversees the use of gene therapy and other cutting edge biomedical technologies voted today to let researchers move ahead with the CRISPR-Cas9 clinical trial.

    Jun 21, 2016

  • Illumina's Flatley speaks of genomic future

    The San Diego Union-Tribune | Illumina's Flatley speaks of genomic future. Longtime CEO stepping down to become chairman, looks for near-universal use of genome sequencing.

    Jun 21, 2016